Blue Latitude Health wins PMEA 2015 Innovation award

Blue Latitude Health wins PMEA2015 award for Lilly Medical Information Cascade

We are pleased to announce that Blue Latitude Health has won a PMEA 2015 award for our work with Eli Lilly and Company on the Lilly Medical Information Cascade. The project was shortlisted in two categories, ‘Excellence in Physicians/Healthcare Provider Support Programmes’ and ‘Innovation’, winning in Innovation

Regional campaigns: Improving local uptake while staying on-message


Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and healthcare systems can be so wildly variable and complicated. A lot of work goes into a regional marketing strategy, but without coherent execution at the local level, the campaign loses impact.

Senior Account Manager Dolan Desai talks us through the five core considerations that will allow you to maximise impact across a region through coherent execution.

10 tips for developing insightful pre-launch positioning


By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Head of Insight Martine Leroy delivers her top tips on how to keep insight at the centre of your positioning to best support your brand.

‘The Maggie’s Blues’ take on the London Culture Crawl for Maggie’s Centres

Culture Crawl Getting Ready

Blue Latitude Health is a healthcare creative marketing consultancy, and part of our day-to-day work involves working closely with oncology healthcare professionals and patients to understand their experiences. And we care deeply about the work of charities that support cancer research, patients and families. Together, as the self-appointed ‘Maggie’s Blues’, Kavita and Martine took part in the Culture Crawl London event organised by Maggie’s Centres, a UK-based cancer support charity organisation that does make an incredible difference to patients and their families.

Bigger than brand: Portfolio positioning for pharma

Sketchnote - Bigger than brand - Blue Latitude

For many years, pharma have reduced the impact of loss of exclusivity (LOE) by launching alternative molecules to treat the same condition. Whilst the commercial intention of this is to maximise the value gained from a therapy area, the execution of a portfolio strategy can impact this if done poorly. With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Tackling biosimilars – how to handle the threat to pharma brands


Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.

Janssen extends the Blue Latitude contract for strategic marketing services to the EMEA region


We are pleased to announce that Blue Latitude have been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region. Following this renewed three year contract, we will continue our successful partnership with Janssen, offering our full breadth of services across a wide range of therapy areas.